Vertex shareholders elect all 11 directors, reject golden parachute proposal at 2025 annual meeting

VERTEX PHARMACEUTICALS INC / MA

All 11 director nominees elected with majority support; Bruce Sachs received lowest 'for' votes at 211.6M.
Ratification of Ernst & Young as auditor for FY2025 passed with 229.4M votes for, 6.9M against.
Advisory vote on 2024 named executive officer compensation approved: 208.9M for, 17.0M against.
Shareholder proposal on excessive golden parachutes rejected: 84.1M for, 141.6M against.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.